Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / AstraZeneca settles patent case with Handa
BackBack

AstraZeneca settles patent case with Handa

AstraZeneca settles patent case with Handa

AstraZeneca Plc’s Seroquel schizophrenia medication. Photo: BloombergPremium

AstraZeneca Plc’s Seroquel schizophrenia medication. Photo: Bloomberg
AstraZeneca Plc’s Seroquel schizophrenia medication. Photo: Bloomberg

AstraZeneca said Friday that Handa Pharmaceuticals of Fremont, California, had accepted that AstraZeneca had valid patents for Seroquel XR for the treatment of depression.

Seroquel is the third-largest selling drug for the London-based pharmaceutical company. Handa announced in December that it had won preliminary approval to distribute its generic product in the United States.

As part of the settlement, AstraZeneca says it has granted Handa a license to enter the US market with a generic version of Seroquel by 1 November 2016. AstraZeneca holds several patents on the drug which expire between March 2012 and November 2017.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 30 Sep 2011, 02:13 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie